Literature DB >> 25201495

Symmetry and order parameter dynamics of the human odometer.

Mohammad Abdolvahab1, Claudia Carello, Carla Pinto, M T Turvey, Till D Frank.   

Abstract

Bipedal gaits have been classified on the basis of the group symmetry of the minimal network of identical differential equations (alias cells) required to model them. Primary bipedal gaits (e.g., walk, run) are characterized by dihedral symmetry, whereas secondary bipedal gaits (e.g., gallop-walk, gallop- run) are characterized by a lower, cyclic symmetry. This fact has been used in tests of human odometry (e.g., Turvey et al. in P Roy Soc Lond B Biol 276:4309-4314, 2009, J Exp Psychol Hum Percept Perform 38:1014-1025, 2012). Results suggest that when distance is measured and reported by gaits from the same symmetry class, primary and secondary gaits are comparable. Switching symmetry classes at report compresses (primary to secondary) or inflates (secondary to primary) measured distance, with the compression and inflation equal in magnitude. The present research (a) extends these findings from overground locomotion to treadmill locomotion and (b) assesses a dynamics of sequentially coupled measure and report phases, with relative velocity as an order parameter, or equilibrium state, and difference in symmetry class as an imperfection parameter, or detuning, of those dynamics. The results suggest that the symmetries and dynamics of distance measurement by the human odometer are the same whether the odometer is in motion relative to a stationary ground or stationary relative to a moving ground.

Entities:  

Mesh:

Year:  2014        PMID: 25201495     DOI: 10.1007/s00422-014-0627-1

Source DB:  PubMed          Journal:  Biol Cybern        ISSN: 0340-1200            Impact factor:   2.086


  1 in total

1.  Assessing the relative contribution of vision to odometry via manipulations of gait in an over-ground homing task.

Authors:  Steven J Harrison; Nicholas Reynolds; Brandon Bishoff; Nicholas Stergiou
Journal:  Exp Brain Res       Date:  2021-02-25       Impact factor: 1.972

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.